Box 611, 501 Smyth Road
Ottawa Ontario
Canada
K1H 8L6
Sigle : BioCanRx
Adresse Internet : https://biocanrx.com

  Programme(s) de recherche actif(s)

  Projet(s) actif(s)
    Development of GMP-grade anti-Nectin-4 radioimmunoconjugates, and clinical trial enabling studies for phase 1 trial against Nectin-4 positive NSCLC and TNBC